Tumor Ablation Market Growth, Industry Trends To 2022 by Grand View Research, Inc.

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological advancements in the field of thermal ablation techniques are the most prominent drivers of the market.
Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry.
Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone.
In terms of technological advancement, companies such as SonaCare Medical are coupling ablation techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable physicians to enhance patient care experience, thereby promoting market growth.
The industry is also anticipated to witness mergers and joint collaborations as a tool to curb rising competition. For instance, Boston Scientific Corporation acquired C.R. Bard Electrophysiology, which led to a 48.0% hike in profit for the former company.
Browse full research report on Global Tumor Ablation Market: grandviewresearch.com/industry-analysis/tumor-ablation-market
Further key findings from the study suggest:
• Microwave ablation technology is expected to be the fastest growing segment over the forecast period at a CAGR of over 15.0%. Reduction in the procedure time and low cost for treatment are some of the attributes favoring growth.
• In terms of treatment, surgical ablation is predicted to form the largest market by 2022 with about 35.0% share. Liver and lung cancer ablation require surgical procedures, and since these form the largest and fastest growing segments, they concomitantly propel surgical ablation growth.
• Lung cancer forms the most lucrative market and is anticipated to be the fastest growing segment over the forecast period. By 2022, it is expected to contribute about 15.0% of the revenue share owing to its rising prevalence rate across the globe.
• According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.
• Major players of the market include HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To retain market leadership, players such as Medtronic are working towards acquiring other companies and expanding their portfolio. For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation System from Baylis Medical.
Read detailed report or request for sample of this research report:
http://www.grandviewresearch.com/industry-analysis/tumor-ablation-market/request
Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region
Global Tumor Ablation Technology Outlook (USD million), 2012 – 2022
• Radiofrequency
• Microwave ablation
• Cryoablation
• Other ablation technologies
Global Tumor Ablation Treatment Outlook (USD million), 2012 – 2022
• Surgical tumor ablation
• Laparoscopic tumor ablation
• Percutaneous tumor ablation
Global Tumor Ablation Application Outlook (USD million), 2012 – 2022
• Liver cancer
• Breast cancer
• Lung cancer
• Prostate cancer
• Other cancers
Tumor Ablation Region Outlook (USD million), 2012 – 2022
• North America
o U.S.
- U.S. tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- U.S. tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- U.S. tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
o Canada
- Canada tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- Canada tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- Canada tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
• Europe
o UK
- UK tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- UK tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- UK tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
o Germany
- Germany tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- Germany tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- Germany tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
• Asia Pacific
o Japan
- Japan tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- Japan tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- Japan tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
o China
- China tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- China tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- China tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
• Latin America
o Brazil
- Brazil tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- Brazil tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- Brazil tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
o Mexico
- Mexico tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- Mexico tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- Mexico tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
• MEA
o South Africa
- South Africa tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- South Africa tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- South Africa tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
o Saudi Arabia
- Saudi Arabia tumor ablation market technology outlook
- Radiofrequency
- Microwave ablation
- Cryoablation
- Other ablation technologies
- Saudi Arabia tumor ablation market treatment outlook
- Surgical tumor ablation
- Laparoscopic tumor ablation
- Percutaneous
- Saudi Arabia tumor ablation market application outlook
- Liver cancer
- Breast cancer
- Lung cancer
- Prostate cancer
- Other cancer
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
email: sales@grandviewresearch.com
Web: www.grandviewresearch.com

This release was published on openPR.